There have been increasing reports of tattoo-associated mycobacterial infections in recent years, with a number of outbreaks documented worldwide. This has therefore become a public health concern. Nontuberculous mycobacteria (NTM) are capable of producing skin and soft tissue infections typically via inoculation during surgery, trauma, and cosmetic procedures. We present a case of tattoo-associated cutaneous infection caused by , a rare species of rapidly growing NTM. A 25-year-old man developed a rash on his left lower leg 4 weeks after he underwent professional tattooing. A skin swab identified . complex. Based on susceptibility testing, a course of oral ciprofloxacin and trimethoprim/sulfamethoxazole was initiated, with significant improvement observed after 5 weeks. We speculate that the mechanism of inoculation was a result of either the artist using nonsterile water to dilute black ink to gray or from use of contaminated prediluted gray ink. The Therapeutic Goods Administration does not have regulatory authority over the sterility of tattoo inks or practices in Australia. Instead, tattoo practices are regulated by local government jurisdictions. Because of the variability seen in clinical presentation and challenges associated with organism identification, a high index of suspicion is required to diagnose mycobacterial infections. Infection caused by NTM should be considered in the differential diagnosis of tattoo-associated dermatological complications, particularly in patients who have chronic lesions, negative bacterial cultures, and fail to respond to standard antibiotic therapy. Mandatory regulations for safe tattoo practices should be considered to prevent outbreaks and ensure public safety.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740008PMC
http://dx.doi.org/10.1159/000520255DOI Listing

Publication Analysis

Top Keywords

tattoo-associated cutaneous
8
cutaneous infection
8
mycobacterial infections
8
infection caused
8
tattoo practices
8
tattoo-associated
4
infection case
4
case report
4
report review
4
review literature
4

Similar Publications

Sarcoidosis is a systemic granulomatous disease with variable ocular involvement. The most common ocular manifestation is uveitis, which can have potentially sight threatening complications such as glaucoma. We present the case of a man in his 30s with sarcoidosis and recurrent anterior uveitis, necessitating surgical intervention to control intraocular pressure and prevent further glaucomatous optic neuropathy progression.

View Article and Find Full Text PDF
Article Synopsis
  • The popularity of tattoos has led to more skin reactions, including infections, allergies, and a rare condition called tattoo-induced cutaneous lymphoid hyperplasia (CLH), which mimics skin cancer.
  • A study from September 2021 to May 2023 used advanced non-invasive tools like reflectance confocal microscopy (RCM) and line-field confocal optical coherence tomography (LC-OCT) to analyze suspicious tattoo-related lesions in five patients diagnosed with CLH.
  • Findings showed that both RCM and LC-OCT effectively identified features of CLH, such as lymphocyte infiltration patterns, and they may offer a cost-effective and efficient alternative to traditional biopsies for diagnosing tattoo-related skin complications in the future.
View Article and Find Full Text PDF
Article Synopsis
  • Sarcoidosis is an inflammatory disease causing granulomas in various organs, and its cause is unknown; the study investigates sirolimus, an mTOR inhibitor, as a potential treatment for cutaneous sarcoidosis.* -
  • The research was conducted at the Vienna General Hospital, enrolling patients with persistent and glucocorticoid-resistant cutaneous sarcoidosis, and involved two phases: a double-blind topical treatment followed by systemic treatment.* -
  • The main goal was to measure changes in the Cutaneous Sarcoidosis Activity and Morphology Index (CSAMI) after treatments, while also monitoring for adverse effects related to sirolimus.*
View Article and Find Full Text PDF

Tattoo-associated cutaneous reactions have become quite frequent given the increasing percentage of tattooed subjects globally and also in Italy. On the other hand, the increasing use of target therapy is showing the ability of these drugs to affect the immune system and also cause adverse tattoo-related reactions. In this paper, we report a case of a 42-year-old patient with stage-IIID melanoma undergoing treatment with Dabrafenib and Trametinib.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!